A purposeful calling
to help individuals and teams
reach their full potential
As a business leader, you shoulder a heavy burden to lead effectively in a marketplace that continues to grow in complexity and uncertainty.
We help guide you to be your best and deliver great results.
As a business leader, you shoulder a heavy burden to lead effectively in a marketplace that continues to grow in complexity and uncertainty.
We help guide you to be your best and deliver great results.
How do you be your best to deliver over the long term for your people and your company? As the
Over the last decade or so, some of the leading companies in the world have made significant investments in employee
With Veteran’s Day occurring yesterday on Friday November 11th, I wanted repost a prior blog on some learnings from Veterans
How do you be your best to deliver over the long term for your people and your company? As the
Everyone needs a trusted adviser to be their best. That includes you and your top talent.
Everyone needs a trusted adviser to be their best. That includes you and your top talent.
Effective leaders stand in the gap between industry leading performance and average company performance.
Effective leaders stand in the gap between industry leading performance and average company performance.
Looking Back – What I Learned When I Left a Great Company. Available Now on Amazon.
Looking Back – What I Learned When I Left a Great Company. Available Now on Amazon.
David Esposito is a seasoned healthcare executive and combat veteran. As a CEO and President, David built and scaled multiple healthcare companies that resulted in successful exits to strategic buyers (Armune BioScience sold to Exact Sciences [EXAS] in December 2017) and Phadia US/AB (sold to Thermo Fisher Scientific [TMO] in September 2011).
David Esposito is a seasoned healthcare executive and combat veteran. As a CEO and President, David built and scaled multiple healthcare companies that resulted in successful exits to strategic buyers (Armune BioScience sold to Exact Sciences [EXAS] in December 2017) and Phadia US/AB (sold to Thermo Fisher Scientific [TMO] in September 2011).
We’ll send you a weekly digest of current posts…